I predicted this a week ago: I anticipate that th

Quote:

---

I anticipate that the FDA will next grant Gilead a 2-week combo trial with remdesivir and an anti-inflamatory, since CytoDyn has apparently rejected being involved.

And, I anticipate the FDA will quickly rubber stamp an approval. It's clear from Fauci's statements that this is the direction they are going.

Read More: https://investorshangout.com/post/view?id=575...z6LsUJO3lK

---